Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intramuscular vs. Enteral Penicillin Prophylaxis to Prevent Progression of Latent Rheumatic Heart Disease
NCT05693545Phase 2Active, not recruiting
- Sponsor
- Cincinnati Children's Hospital Medical Center
- Start
- Sep 2023
- Primary completion
- Mar 2027
- Modality
- Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
A Phase 2 trial of phenoxymethylpenicillin in rheumatic heart disease (RHD), sponsored by Cincinnati Children's Hospital Medical Center. Started Sep 2023; status: active, not recruiting.
02
Drugs
phenoxymethylpenicillin
03
Conditions
rheumatic heart disease (RHD)
Beyond the preview
Go deeper on NCT05693545.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05693545.